Liver injury remains the most common cause of clinical trial termination and a main cause of postmarketing drug withdrawals.
The reason for early trial termination was a major change in RRT equipment and procedures that was beyond the investigators' control.
Cancer phase II trials are often designed as multistage trials (two stages being most common) allowing early trial termination in case of a low response rate, in order to avoid giving patients an ineffective treatment and wasting resources.
Articles were included when they: 1. reported on a controlled clinical trial, randomized or quasi-randomized, investigating any type of therapeutic intervention (i.e. drug, procedure, behavioral, health strategy, or other) and including, but not necessarily confined to, participants between 0-18 years; 2. reported on the use of a DMC or interim analysis or early trial termination.
This is also your interest, of course but only if the settlement is preferable to your no-settlement alternatives, such as a trial or termination of your relationship with the other party.
Adaptive designs may incorporate a broad spectrum of potential changes to trial conduct, with early trial termination rules based on statistical boundaries being one of the simplest adaptations.
We compared the Bayesian fractional additivity model to a conventional analysis by measuring the expected proportion of failures, sample size at trial termination, time to termination, and root mean squared error of final estimates.
Path curvature was taken as the mean perpendicular distances of individual points along the path to a straight line connecting the origin to the target (from movement onset to trial termination).
We review the events leading up to and the rationale behind the DMC recommendations for suspension of patient enrollment and trial termination.
The numerical results presented in this work include the type of simulation information that aid review boards in understanding design performance, such as average sample size and frequency of early trial termination, which we hope will augment early-phase trial design in cancer immunotherapy.
The purpose of this paper was to demonstrate a group-sequential analysis strategy in an intra-observer study on quantitative FDG-PET/CT measurements, illuminating the possibility of early trial termination which implicates significant potential time and resource savings.
